Cryptic Myc and Bcl2 Rearrangements Are Among a Range of Genetic Mechanisms Underlying the Double Hit Signature in Non-Double Hit Diffuse Large B-Cell Lymphoma

Hematological Oncology - United Kingdom
doi 10.1002/hon.42_2629
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

­­The Double Hit Signature Identifies Double-Hit Diffuse Large B-Cell Lymphoma With Genetic Events Cryptic to FISH

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

Sequence Based Analysis of U-2973, a Cell Line Established From a Double-Hit B-Cell Lymphoma With Concurrent MYC and BCL2 Rearrangements

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2012English

Targeting MYC Activity in Double-Hit Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements With Epigenetic Bromodomain Inhibitors

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Transformation of Double-Hit Large B-Cell Lymphoma Into B-Lymphoblastic Lymphoma: A Case Report

Journal of Hematopathology
Forensic MedicinePathologyHematologyHistology
2011English

Double-Hit B-Cell Lymphomas

Blood
BiochemistryImmunologyCell BiologyHematology
2011English

A Rare Case of IGH/MYC and IGH/BCL2 Double Hit Primary Plasma Cell Leukemia

Haematologica
Hematology
2014English

Double‐hit Lymphoma: So What?

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Diffuse Large B-Cell Lymphoma With Combined TP53 Mutation and MIR34A Methylation: Another &Ldquo;double Hit” Lymphoma With Very Poor Outcome?

Oncotarget
Oncology
2014English

Double Hit and Double Expressors in Lymphoma: Definition and Treatment

Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy